Core Viewpoint - The A-share market has 47 stocks involved in the cosmetics industry chain, with 18 stocks reporting year-on-year growth in net profit for the first three quarters, indicating a positive trend in the sector [1] Group 1: Performance Overview - 18 stocks achieved year-on-year growth in net profit, with a success rate of approximately 41.67% [1] - Among the stocks with profit growth, Fujilai, Qingsong Co., and Xianggang Technology reported significant increases in net profit, with growth rates of 430.16%, 246.98%, and 186.19% respectively [1] Group 2: Research and Development Investment - The majority of the stocks with profit growth focus on R&D investment, with 12 out of the 18 stocks increasing their R&D expenses in the first three quarters [1] - Xianggang Technology, Ruoyuchen, and Shuiyang Co. had R&D expense growth rates exceeding 30% [1] Group 3: Capital Flow - 16 stocks have received net financing inflows since December, indicating strong investor interest [1] - Lihua Science and Technology, Aimeike, and Zhongyuan Qihe led in net financing inflows, with amounts reaching 58.53 million, 48.75 million, and 44.02 million respectively [1]

Market Overview - On December 12, A-share market indices showed mixed performance, with the Shanghai Composite Index slightly down by 0.04%, while the Shenzhen Component Index and the ChiNext Index rose by 0.57% and 0.6% respectively [1] - Sectors such as nuclear fusion, nuclear power, ultra-high voltage, and superconductors saw significant gains, with concept indices rising over 3% [1] Nuclear Power Sector - The nuclear power sector experienced a strong rally, with the concept index increasing by 3.17%. Key stocks like Sun Cable, Zhongchao Holdings, Changcheng Electric, and Guoji Heavy Industry reached their daily limit up [2] - Over 4 billion yuan of institutional funds flowed into the nuclear power sector [2] - China Western Electric also surged to its daily limit, with a buy order volume of 1.2577 million shares and over 1.1 billion yuan in buy orders [4] - Recent achievements in China's nuclear power projects include the successful grid connection of the world's largest "Hualong One" nuclear power base and the initiation of construction at the Shandong Zhaoyuan nuclear power base [4] - Huajin Securities reports that the advantages of nuclear power are becoming more evident as the grid faces increasing pressure from intermittent renewable energy sources [4] Cosmetics Industry - The National Medical Products Administration released a three-year action plan (2026-2028) aimed at enhancing the production quality management system for cosmetics companies [5] - The plan encourages the use of intelligent and diversified production methods to improve quality and efficiency, and supports the development of a standardized, intelligent, and internationalized cosmetics industry [5] - The Chinese cosmetics market is projected to maintain a scale exceeding 1 trillion yuan in 2024, with over 5,700 companies in the sector [6] - The competition among cosmetics brands is intensifying, with domestic brands making significant advancements in R&D and market strategies [6] - A total of 47 A-share companies are involved in the cosmetics industry, with notable stock performances including Liren Lizhuang, which rose by 4.75% [7] - Among 18 companies reporting profit growth, Fujilai and Qingsong Co. showed significant increases in net profit, with growth rates of 430.16% and 246.98% respectively [7] - R&D expenditures are increasing among profitable companies, with 12 out of 18 companies reporting growth in R&D spending [8]

Group 1 - Guangdong Marubi Biotechnology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange [1] - The joint sponsors for the listing are Goldman Sachs and CITIC Securities [1]

天眼查App显示，近日，利辛县溯美化妆品有限公司成立，法定代表人为凡莉，注册资本1万人民币， 经营范围为一般项目：化妆品批发；化妆品零售；个人卫生用品销售；日用百货销售（除许可业务外， 可自主依法经营法律法规非禁止或限制的项目）许可项目：生活美容服务（依法须经批准的项目，经相 关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）。 ...

Core Viewpoint - Marubi Biotechnology has submitted a listing application to the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities as joint sponsors. The company ranks third in the Chinese market for recombinant collagen skincare products by retail sales in 2024, focusing on anti-aging skincare through synthetic biology technology [1][2]. Group 1: Company Overview - Marubi operates two main brands: Marubi (丸美) and L'HOTEL (恋火). The Marubi brand specializes in eye and facial anti-aging care, holding the top position in retail sales for eye care brands in China from 2021 to 2024. L'HOTEL focuses on base makeup products, ranking third among domestic base makeup brands and fifth overall in China for retail sales in 2024 [2]. - The company has developed over 80 proprietary ingredients, including recombinant double collagen and SPGβ-glucan, with more than 30 products achieving large-scale production. It operates two production bases in Guangzhou, equipped with high-density fermentation and purification processes for recombinant collagen production [2]. Group 2: Industry Position and Innovations - According to a report by Frost & Sullivan, Marubi ranks third in the recombinant collagen skincare segment in China by retail sales for 2024. The company has successfully developed recombinant double collagen, an engineered product that combines type I and type III collagen using translation pause and C-PRO loop technology [1]. - As of September 30, 2025, Marubi is the first and only company in China approved as a national research center for recombinant functional protein technology, having been recognized as a key drafting unit for the industry standard "Recombinant Soluble Collagen" by the Ministry of Industry and Information Technology [1].

国家药监局表示，我国目前正从制妆大国向制妆强国跨越，"十四五"以来，我国发布170项相关标准， 截至目前，我国化妆品注册备案产品超过230万个，注册备案新原料324个，国产化妆品市场份额已超过 55.2%；"十四五"期间，国家药监局组织飞行检查109家次，全国查处化妆品案件12.9万件，货值金额约 39亿元，有力震慑了违法犯罪行为。 （文章来源：央视新闻） 记者今天从国家药监局获悉，《化妆品企业生产质量管理体系提升三年行动计划（2026—2028年）》刚 刚发布，监管部门将帮助中小规模化妆品企业破解原料合规性不足、生产过程与注册备案资料一致性等 体系运行不畅难题，提升关键岗位人员质量管理能力，鼓励省级药监部门制定适应数字化生产的质量管 理审查要求，推动"外设仓库放行"等制度，探索运用人工智能等手段辅助检查和风险研判。 ...

天眼查App显示，近日，南京美初妍化妆品有限公司成立，法定代表人为薛紫东，注册资本100万人民 币，经营范围为一般项目：化妆品零售；生物基材料技术研发；海洋生物活性物质提取、纯化、合成技 术研发；个人卫生用品销售；生物基材料制造；生物质能技术服务；技术服务、技术开发、技术咨询、 技术交流、技术转让、技术推广；日用化学产品销售；互联网销售（除销售需要许可的商品）；销售代 理；日用品销售；卫生用杀虫剂销售；日用百货销售；针纺织品销售；珠宝首饰批发；珠宝首饰制造； 珠宝首饰零售；工艺美术品及收藏品零售（象牙及其制品除外）；美发饰品销售；金银制品销售；养生 保健服务（非医疗）；货物进出口；技术进出口；进出口代理；会议及展览服务（除依法须经批准的项 目外，凭营业执照依法自主开展经营活动）。 ...

天眼查App显示，近日，哈尔滨云辞化妆品有限公司成立，法定代表人为朱彩虹，注册资本1万人民 币，经营范围为一般项目：化妆品零售；信息咨询服务（不含许可类信息咨询服务）；广告发布；社会 调查（不含涉外调查）；组织文化艺术交流活动；企业形象策划；广告制作；社会经济咨询服务；销售 代理；互联网销售（除销售需要许可的商品）；日用百货销售；市场调查（不含涉外调查）；市场营销 策划；图文设计制作；广告设计、代理；会议及展览服务。 ...

据港交所文件：广东丸美生物技术股份有限公司向港交所提交上市申请书。 ...

Core Insights - The company Fuhua Jia (301371) reported that as of December 10, 2025, the number of shareholders is 16,290 [1] Summary by Categories - **Company Information** - Fuhua Jia has a total of 16,290 shareholders as of the specified date [1]